Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial of a vaccine therapy for stage III or IV ovarian epithelial cancer. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED